The Tesla CEO said that Neuralink, another one of his tech companies, planned on implanting its new brain chip, Blindsight, into a human patient for the first time in late 2025. Newsweek contacted ...

Neurotechnology company Neuralink has secured a breakthrough device designation from the US Food and Drug Administration (FDA) for its Blindsight device. This advanced technology promises to ...

Neuralink’s Blindsight is the latest, as the company announced Tuesday on X. Blindsight is a new iteration of a technology that has been used for decades to experimentally restore very limited ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight.

Neuralink’s Blindsight device is designed to enable individuals who are completely blind, including those who have lost both eyes or their optic nerve, to perceive visual images. It even aims to ...